Throughout Orange County, rates of SARS-CoV-2 infection appear to be leveling off after declining for several weeks. The Omicron BA.2 sub-variant has been increasing in prevalence as cases decline. Yesterday, the California Department of Public Health (CDPH) released a Health Alert (CAHAN) providing updated information on the status of therapeutics...
(Santa Ana, CA) – On March 30, the Centers for Disease Control and Prevention issued updated recommendations for a second booster dose of the Moderna (SpikeVax) and Pfizer (Comirnaty) COVID-19 vaccine in certain individuals. The second booster dose is expected to be available throughout Orange County, including the OC Health...
Document Date EMCC Agenda 04/07/2022 Attachment 1...
(Santa Ana, CA) - The OC Health Care Agency (HCA) encourages community members to drop-off expired, unused or unwanted prescription medications on "National Take Back Day," Saturday, April 30, from 10 a.m. to 2 p.m. at numerous locations throughout Orange County. “This is a great opportunity for individuals to clean...
(Santa Ana, CA) – In response to rising COVID-19 cases and hospitalization trends throughout the U.S., combined with easing public health restrictions for travel and upcoming holidays leading to larger gatherings, the OC Health Care Agency strongly advises Orange County residents and visitors to take preventative measures to reduce their...
(Santa Ana, CA) – The Orange County (OC) Equity Map, a public-private partnership between AdvanceOC, the Orange County Board of Supervisors (Board), and the OC Health Care Agency (HCA) is recognized by the Southern California Association of Governments (SCAG) with a Sustainability Award in the category of Equity. The OC...
The Orange County Healthcare Agency wants to make sure providers are aware of the potential for Monkeypox Virus infection in patients presenting with fever and clinically consistent rash. A case of Monkeypox has been identified in a US resident who travelled to Canada and in the last month multiple cases...
Today, the Centers for Disease Control and Prevention released a Health Advisory with considerations around the phenomena of rebound, after treatment of patients with mild to moderate COVID-19, with Paxlovid (nirmatrelvir tablets; ritonavir tablets).